Patents by Inventor Jonathan U. Peled

Jonathan U. Peled has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR DETECTING RISK OF CANCER RELAPSE
    Publication number: 20230416834
    Abstract: The present invention relates to methods and compositions for reducing the risk of cancer relapse in a subject who has received cancer treatment. It is based, at least in part, on the discovery that a restricted fraction of the gut microbiota, including the bacteria Streptococcus anginosus, Parvimonas micra, Acidaminococcus intestini, Eubacterium limosum, Clostridium glycyrrhizinilyticum, Desulfosporosinus lacus, Eubacterium biforme, Anaerofustis stercorihominis, Pseudoramibacter alactolyticus, Peptococcus niger, Armatimonas rosea, Saccharofermentans acetigenes, Finegoldia magna, Levyella massiliensis, Gallicola barnesae, Murdochiella asaccharolytica, and Eubacterium brachy are associated with a reduced risk of cancer relapse.
    Type: Application
    Filed: March 6, 2023
    Publication date: December 28, 2023
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Marcel Van Den Brink, Robert Jenq, Jonathan U. Peled
  • METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING SUBJECTS AT RISK OF POOR CANCER SURVIVAL
    Publication number: 20230151430
    Abstract: The present disclosure relates to compositions and methods for predicting cancer survival in a subject after receiving a treatment (e.g., allogeneic hematopoietic-cell transplantation). The present disclosure further discloses compositions and methods for treating said subject.
    Type: Application
    Filed: August 18, 2022
    Publication date: May 18, 2023
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Jonathan U. Peled, Marcel R.M. Van Den Brink, Antonio Gomes
  • Methods and compositions for detecting risk of cancer relapse
    Patent number: 11597979
    Abstract: The present invention relates to methods and compositions for reducing the risk of cancer relapse in a subject who has received cancer treatment. It is based, at least in part, on the discovery that a restricted fraction of the gut microbiota, including the bacteria Streptococcus anginosus, Parvimonas micra, Acidaminococcus intestini, Eubacterium limosum, Clostridium glycyrrhizinilyticum, Desulfosporosinus lacus, Eubacterium biforme, Anaerofustis stercorihominis, Pseudoramibacter alactolyticus, Peptococcus niger, Armatimonas rosea, Saccharofermentans acetigenes, Finegoldia magna, Levyella massiliensis, Gallicola barnesae, Murdochiella asaccharolytica, and Eubacterium brachy are associated with a reduced risk of cancer relapse.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: March 7, 2023
    Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Marcel Van Den Brink, Robert Jenq, Jonathan U. Peled
  • METHODS AND COMPOSITIONS FOR DETECTING RISK OF CANCER RELAPSE
    Publication number: 20180274036
    Abstract: The present invention relates to methods and compositions for reducing the risk of cancer relapse in a subject who has received cancer treatment. It is based, at least in part, on the discovery that a restricted fraction of the gut microbiota, including the bacteria Streptococcus anginosus, Parvimonas micra, Acidaminococcus intestini, Eubacterium limosum, Clostridium glycyrrhizinilyticum, Desulfosporosinus lacus, Eubacterium biforme, Anaerofustis stercorihominis, Pseudoramibacter alactolyticus, Peptococcus niger, Armatimonas rosea, Saccharofermentans acetigenes, Finegoldia magna, Levyella massiliensis, Gallicola barnesae, Murdochiella asaccharolytica, and Eubacterium brachy are associated with a reduced risk of cancer relapse.
    Type: Application
    Filed: September 2, 2016
    Publication date: September 27, 2018
    Inventors: Marcel Van Den Brink, Robert Jenq, Jonathan U. Peled